KRISTEN GAROFALO: Open Payments
NPI 1063062933 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 91 payments from 18 companies in 2025. Trend: 2023 $1,447 · 2024 $1,203 · 2025 $2,493
Food & beverage: $2,493
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $797 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $273 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| Merck Sharp & Dohme LLC | 10 | $175 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $159 |
| Actelion Pharmaceuticals US, Inc. | 9 | $146 |
| Alnylam Pharmaceuticals Inc. | 7 | $125 |
| PFIZER INC. | 7 | $121 |
| BridgeBio Pharma, Inc. | 5 | $95 |
Products named: Rapiblyk, JARDIANCE, FARXIGA, LifeVest, UPTRAVI, WINREVAIR, VYNDAQEL, Adempas.
Industry payments across NJ — which companies pay providers there.
